Shareholder Alert: Ademi LLP Investigates Whether Alimera Sciences, Inc. Has Obtained a Fair Price for Its Public Shareholders
Shareholder Alert: Ademi LLP Investigates Whether Alimera Sciences, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, June 24, 2024 /PRNewswire/ -- Ademi LLP is investigating Alimera (Nasdaq: ALIM) for possible breaches of fiduciary duty and other violations of law in its transaction with ANI Pharmaceuticals.
Ademi LLP正在调查Alimera(Nasdaq: ALIM)与ANI Pharmaceuticals交易可能存在的违反信托职责和其他法律的行为。.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
点击此处了解如何加入或致电Guri Ademi,免费电话:866-264-3995。您不需要付出任何费用或承担任何责任。
In the transaction, Alimera public shareholders will receive only $5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027. The transaction agreement unreasonably limits competing transactions for Alimera by imposing a significant penalty if Alimera accepts a competing bid. Alimera insiders will receive substantial benefits as part of change of control arrangements.
在该交易中,Alimera的公共股东将在收盘时仅获得每股5.50美元的现金以及一个不可交易的附带价值权(CVR),该权利代表在2026年和2027年达到特定净收入目标时获得每股高达0.50美元的权利。该交易协议通过对Alimera提出竞购而不合理地限制了竞争交易,如果Alimera接受竞争性报价,则会面临重大处罚。作为变更控制安排的一部分,Alimera内部人员将获得大量利益。
We are investigating the conduct of Alimera's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我们正在调查Alimera的董事会的行为,以及他们是否履行了对所有股东的信托职责。
If you own Alimera common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您拥有Alimera普通股并希望获得更多信息,请通过[email protected]或免费电话联系Guri Ademi:866-264-3995或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我们专门从事全国范围内有关收购、合并和个人股东权利的股东诉讼。欲了解更多信息,请随时与我们联系。律师广告。之前的业绩不保证类似的结果。
Contacts
联系方式
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免费电话:(866) 264-3995
传真:(414) 482-8001
SOURCE Ademi LLP
信息来源:Ademi LLP